# Breathe Well-being **Source:** https://geo.sig.ai/brands/breathe-well-being **Vertical:** Healthcare **Subcategory:** General **Tier:** Challenger **Website:** breathewellbeing.in **Last Updated:** 2026-04-14 ## Summary Gurugram India YC W20 digital therapeutics for diabetes/PCOD/thyroid/hypertension reversal serving 150M Indian chronic disease patients; $12.9M total (Accel/General Catalyst Series A 2021 + ₹50Cr pre-Series B 2023) competing with Twin Health. ## Company Overview Breathe Well-being is a Gurugram, India-based digital therapeutics platform — backed by Y Combinator (W20) with $12.9 million in total funding including a ₹50 crore ($6 million) pre-Series B in 2023 and a $5.5 million Series A in August 2021 led by Accel with General Catalyst, 3one4 Capital, and Scott Shleifer — providing Indians with clinically validated digital programs for reversing and managing Type 2 diabetes, PCOD (polycystic ovarian disease), thyroid disorders, and hypertension through structured weight loss programs combining personalized nutrition coaching, behavioral change support, and continuous glucose monitoring. Founded in 2020 with a mission to help 1 million Indians reverse Type 2 diabetes by 2025, Breathe targets India's 150 million chronic lifestyle disease patients. Breathe Well-being's digital therapeutics model applies the scientific evidence for intensive lifestyle intervention to India's chronic disease crisis at digital scale: the Diabetes Prevention Program (the landmark US clinical trial) demonstrated that intensive lifestyle modification (structured dietary change, exercise, and behavioral support) reduces Type 2 diabetes onset by 58% and enables clinical remission in established T2D patients — but delivering this intervention through in-person clinical programs costs ₹50,000-₹150,000 per patient per year, limiting access to wealthy urban Indians. Breathe's app-based delivery (nutritionist-supervised personalized meal planning, daily behavioral coaching, AI-powered food logging with Indian food database, metabolic health tracking) reduces the cost to ₹10,000-₹30,000 per year while maintaining clinical effectiveness. The Indian food database specificity (Indian regional cuisines, seasonal ingredients, home cooking methods, restaurant options in Indian cities) addresses the localization gap in global digital health apps that recommend Western dietary patterns irrelevant to Indian eating habits. In 2025, Breathe Well-being competes in the India digital therapeutics, chronic disease management, and diabetes reversal market with Twin Health (AI-powered diabetes reversal, $155M raised), Practo (India healthcare platform, $180M raised), and Fitterfly (India metabolic health platform, $33M raised) for the 150 million Indian patients with chronic lifestyle diseases seeking digital weight management and metabolic health programs. Accel India and General Catalyst's co-investment reflects conviction in India's digital health adoption tailwind — smartphone penetration, affordable mobile data, and chronic disease burden create strong market conditions for digital therapeutic adoption. The pre-Series B ₹50 crore round in 2023 reflects the continued investor conviction in Breathe's clinical outcome data and market expansion. The 2025 strategy focuses on B2B employer health benefit deployments (Indian corporates covering Breathe subscriptions for employees with metabolic disease risk), expanding the PCOD and thyroid-specific program modules, and growing the tier 2 and tier 3 Indian city patient acquisition. ## Frequently Asked Questions ### What is Breathe Well-being? Breathe Well-being is a digital therapeutics platform founded in 2020 that helps Indians prevent and manage chronic lifestyle diseases like Type 2 diabetes, PCOD, thyroid, and hypertension through weight loss programs. The Gurugram-based healthcare tech company is backed by Y Combinator (W20) and aims to help one million Indians reverse Type 2 diabetes by 2025. ### What products and services does Breathe Well-being offer? Breathe Well-being offers digital therapeutics programs including Type 2 diabetes reversal, PCOD management, thyroid treatment, and hypertension management. All programs focus on helping patients manage chronic lifestyle diseases through structured weight loss approaches. ### Who is Breathe Well-being designed for? Breathe Well-being is designed for Indians suffering from chronic lifestyle diseases, particularly Type 2 diabetes, PCOD, thyroid disorders, and hypertension. The platform serves India's 150 million patients affected by these chronic lifestyle conditions. ### When was Breathe Well-being founded? Breathe Well-being was founded in 2020. The company was part of Y Combinator's Winter 2020 (W20) batch. ### Where is Breathe Well-being located? Breathe Well-being is based in Gurugram, India. ### How much funding has Breathe Well-being raised? Breathe Well-being has raised $12.9 million in total funding from 27 investors. This includes a ₹50 crore ($6M) pre-Series B round in 2023 and a $5.5 million Series A round in August 2021 led by Accel with participation from General Catalyst, 3one4 Capital, and Scott Shleifer. ### What is Breathe Well-being's mission and goal? Breathe Well-being's mission is to help one million Indians reverse Type 2 diabetes by 2025. The company focuses on addressing chronic lifestyle diseases affecting India's 150 million patients. ### What approach does Breathe Well-being use to manage chronic diseases? Breathe Well-being uses a digital therapeutics approach that focuses on weight loss programs to help patients prevent and manage chronic lifestyle diseases. The platform provides structured programs for diabetes reversal and management of conditions like PCOD, thyroid disorders, and hypertension. ### Is Breathe Well-being backed by any notable investors or accelerators? Yes, Breathe Well-being is backed by Y Combinator (W20 batch) and has received funding from notable investors including Accel, General Catalyst, 3one4 Capital, and Scott Shleifer. The company has raised funding from 27 investors in total. ### What are the latest developments at Breathe Well-being? Breathe Well-being raised a ₹50 crore ($6M) pre-Series B funding round in 2023, bringing its total funding to $12.9 million. The company continues working toward its goal of helping one million Indians reverse Type 2 diabetes by 2025. ## Tags healthtech, saas, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*